EN
HI
Summary
As of 29 Sep, 2026, Natco Pharma stock price is ₹828.55. During the trading session, the stock has moved between an intraday low of ₹823.00 and an intraday high of ₹857.85. Over the last 52 weeks, Natco Pharma has traded between ₹789.00 and ₹1226.80.
The stock has recorded a trading volume of 5,02,079 shares,. Its Average Traded Price (ATP) is ₹832.72, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 20 @ ₹828.55.
Natco Pharma has an upper circuit limit of ₹1007.15 and a lower circuit limit of ₹671.45. The total value traded stands at ₹41.81 CR, and the delivery percentage for the day is 43.71%.
The stock is currently traded with a market lot size of 1. Natco Pharma also offers a dividend yield of 0.6%.
Natco Pharma Share Price Chart
Natco Pharma Share Key Metrics
Volume
5.02 L
Market Cap
14840.15 CR
LTQ@LTP
20@828.55
ATP
832.72
Var Margin
18.25 %
Circuit Range
671.45-1007.15
Delivery %
43.71 %
Value
41.81 CR
ASM/GSM
No
Market Lot
1
Natco Pharma Fundamentals
P/E Ratio
13.15
P/B Ratio
1.61
Div. Yield
0.6
Sector P/E
38.06
Sector P/B
3.64
Sec. Div. Yield
0.51
Natco Pharma Resistance and Support
Pivot 841.22
Resistance
First Resistance
848.19
Second Resistance
857.07
Third Resistance
864.04
Support
First Support
832.34
Second Support
825.37
Third Support
816.49
Natco Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 28 2026 | 840.8 | 828.55 | -1.28% | 857.85 | 823 |
| Fri Sep 25 2026 | 844 | 839.29 | -0.32% | 850.09 | 834.25 |
| Thu Sep 24 2026 | 835 | 842 | 0.53% | 855 | 832.25 |
Natco Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-25 | Rights issue of Equity Shares |
| 2026-09-09 | Fund Raising |
| 2026-08-14 | Quarterly Results & Interim Dividend |
| 2026-05-29 | Audited Results |
| 2026-03-24 | Scheme of Arrangement |
| 2026-02-12 | Quarterly Results & Interim Dividend |
| 2025-11-14 | Quarterly Results & Interim Dividend |
| 2025-08-12 | Quarterly Results & Interim Dividend |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-12 | Quarterly Results & Interim Dividend |
| 2024-08-12 | Quarterly Results & Interim Dividend |
Natco Pharma News
Natco Pharma Ltd - 524816 - Board Meeting Outcome for Outcome Of Fund Raising Committee Meeting Approving The Letter Of Offer For Rights Issue
Natco Pharma's fund-raising committee approved the Letter of Offer for a rights issue of up to 1.70 crore equity shares. The issue size is Rs.1,279.40 crore at a price of Rs.750 per share in the ratio of 2:21. The record date for the issue has been fixed as October 1, 2026.
Sep 28 2026 20:52:17
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Natco Pharma has increased its investment in US-based biotechnology firm eGenesis from $14.00 million to $16.70 million. The investment is being executed through its Canadian and US subsidiaries via convertible promissory notes, bringing the total investment in eGenesis to $24.70 million.
Sep 28 2026 14:58:45
Read More
Natco Pharma Management
| Name | Position |
|---|---|
| Chekuri Venkat Ramesh | Company Secretary & Compliance Officer |
| V C Nannapaneni | Chairman & Managing Director |
Natco Pharma Similar Stocks
Alembic Pharmaceuticals Ltd.
854.35
-9.40 (1.09%)
Dr. Agarwal's Health Care Ltd.
503.60
3.60 (0.72%)
Vijaya Diagnostic Centre Ltd.
1501.40
-12.20 (0.81%)
Concord Biotech Ltd.
1392.70
-60.90 (4.19%)
Marksans Pharma Ltd.
331.55
-5.40 (1.60%)
Molbio Diagnostics Ltd.
1237.50
-8.50 (0.68%)
Rainbow Children's Medicare Ltd.
1372.60
-1.60 (0.12%)
Sudeep Pharma Ltd.
1138.80
-26.10 (2.24%)
CORONA Remedies Ltd.
2053.30
-64.40 (3.04%)
Akums Drugs & Pharmaceuticals Ltd.
799.95
-19.60 (2.39%)
Natco Pharma FAQs
The Buying Price of Natco Pharma share is 828.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Natco Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Natco Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Natco Pharma shares is 13.15. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Natco Pharma shares is 1.61. Useful to assess the stock's value relative to its book value.
To assess Natco Pharma’s valuation compare Sector P/E, P/B which are 38.06 & 3.64 with sector averages, along with growth rates and financial metrics.
The Market Cap of Natco Pharma is 14840.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Natco Pharma share price is 1226.80 & 789.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Natco Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NATCOPHARM
Or Download Choice FinX App
Invest in NATCOPHARM
